tag:peatix.com,2011:1 2021-11-15T10:24:24+08:00 Peatix one-north festival 2019 tag:peatix.com,2019:event-1048924 2019-09-14T11:00:00SGT 2019-09-14T11:00:00SGT

Dr. Adrian TeoBiographyAdrian is currently a Principal Investigator at the Institute of Molecular and Cell Biology (IMCB), A*STAR, and an Assistant Professor at the Department of Biochemistry and Department of Medicine, NUS. He obtained his B.Sc. (1st Class) from NUS and then worked on human pluripotent stem cells (hPSCs) with Ray Dunn, Ph.D., and Alan Colman, Ph.D., at ES Cell International Pte. Ltd. followed by IMB. In April 2008, he joined the laboratory of Ludovic Vallier, Ph.D., at the University of Cambridge to pursue his Ph.D., under the AGS(O) scholarship. Concurrently, he was also an Honorary Cambridge Commonwealth Trust Scholar. He completed his Ph.D. in July 2010 and joined the laboratory of Ray Dunn, Ph.D., at IMB as a postdoctoral fellow before heading to the laboratory of Rohit Kulkarni, M.D. Ph.D., at Joslin Diabetes Center, Harvard Medical School. During his fellowship, he obtained HSCI seed grants and a JDRF fellowship to pursue his research interests in using hPSCs for in vitro disease modelling of diabetes. He currently runs the Stem Cells and Diabetes Laboratory with a major focus on differentiating human pluripotent stem cells (hPSCs) into pancreatic cells and cell types affected in diabetic complications to dissect the pathology of diabetes and its complications.SynopsisCurrently, more than 400 million people in the world live with diabetes. In Singapore, we have one of the highest rates of diabetes at >11 %, as compared to a world average of 9 %. In view of the debilitating effects of diabetes, its widespread impact on diabetic complications, and overall healthcare burden on society, diabetes has come under immense spotlight in Singapore in the past few years.